Profile of Beatrice H. Hahn

Total Page:16

File Type:pdf, Size:1020Kb

Profile of Beatrice H. Hahn PROFILE PROFILE Profile of Beatrice H. Hahn Jennifer Viegas Science Writer doctors in the region to use an X-ray ma- chine for diagnostics. “Watching him taught me what it means to be a physician,” says “ Beatrice Hahn, elected to the National Acad- Microbiology and the Institute of Medicine of Hahn. As an adolescent, Hahn liked to draw Discover blood and look at urine slides under the emy of Sciences in 2012, has a longstanding the National Academies. In 2002, ” interest in the origins and evolution of magazine named her one of “The 50 Most microscope. He let me do that, she adds. She human pathogens. She is recognized for Important Women in Science.” Hahn credits further enjoyed discussing cases with him at the dinner table. deciphering the primate origins of human “a lot of luck, good health, a talented team, In school, Hahn was curious to learn immunodeficiency viruses types 1 and 2 and a good husband” for her success. To- about biology. Her original education goals, (HIV-1 and HIV-2) and the malaria para- gether with her husband George Shaw, an- however, were directed toward becoming site Plasmodium falciparum. Hahn has also other international leader in human and a physician. She left her home to attend the developed noninvasive methods to study simian immunodeficiency virus (SIV) re- the zoonotic potential of microbes that in- Technical University of Munich Medical search, Hahn continues to make impres- School, where she earned her doctorate in fect endangered primate species in the wild. sive contributions to this field of medical At present, Hahn is focused on developing medicine in 1982. science. Both Hahn and Shaw are now Hahn’s doctoral thesis (1) foreshadowed a protective human AIDS vaccine by dis- ’ based at the University of Pennsylvania s her later work but revealed some of her past secting the HIV-1 transmission process and Perelman School of Medicine. fl studying the biological properties of newly in uences. As a grade school student she transmitted founder viruses. Early Introduction to Medicine enjoyed herding and milking cows. Rural Over the years, Hahn has earned numer- Born in Munich, Germany, Hahn was in- Bavaria, where cows are a ubiquitous part ous honors, from receiving a National Insti- troduced to medical science by her father, of the landscape, also helped to shape her tutes of Health R37 Merit Award in 2008 to who worked as a primary care physician in thinking. Hahn wondered how bovine election to both the American Academy of rural Bavaria. Her father was among the first illnesses might affect humans, given the closeness of human interaction with cattle. The bovine leukemia virus, the subject of her thesis, is closely related to HTLV-1, a human tumor virus. Robert Gallo and the Discovery of HIV-1 While at the Technical University of Munich, a colleague introduced Hahn to virologist Robert Gallo, then a researcher at the Na- tional Cancer Institute in Bethesda, MD. Gallo’s sister had died at an early age from leukemia, a disease to which he dedicated much of his early research. Gallo was par- ticularly interested in tumor-causing ret- roviruses, which are single-stranded RNA viruses that insert DNA copies of their genome into their host cell to replicate. Bovine leukemia virus is one example of such a retrovirus. Hahn wished to work in Gallo’s labora- tory, but Gallo could not offer her financial support. Hahn successfully applied for a fel- lowship from the German Science Founda- tion. On May 1, 1982, she arrived at the National Cancer Institute. “At the time,” she recalls, “doing basic biomedical re- search in Germany was not an attractive option.” Such opportunities then were far better in the United States. “Funding and This is a Profile of a recently elected member of the National Academy of Sciences to accompany the member’s Inaugural Article George Shaw and Beatrice Hahn. Image courtesy of Beatrice Hahn. 10.1073/pnas.1304288110. www.pnas.org/cgi/doi/10.1073/pnas.1305711110 PNAS Early Edition | 1of3 Downloaded by guest on September 29, 2021 science have since greatly improved in Germany,” she says, but she had decided to remain in the United States. The year before her arrival, clinical cases of the disease now known as AIDS surfaced in the United States. The initial cases were reported among gay men with no known cause of impaired immunity, and yet these individuals often showed symptoms of a rare form of pneumonia and skin cancer. A Centers for Disease Control and Prevention Task Force was formed to monitor the outbreak. Gallo’s laboratory, of which Hahn was now a part, investigated the cause. George Shaw arrived at Gallo’s laboratory in 1983, and Hahn and Shaw’s first collaboration began. A colleague of the couple, Mikulas Popovic, succeeded in culturing and isolating the virus. Hahn and Shaw then cloned its genome. In 1984, Gallo and his collabo- rators published a series of four papers (2– Hahn observes a chimpanzee in Gombe National Park, Tanzania. Image courtesy of 5) in the journal Science demonstrating Brandon Keele. that the isolated retrovirus was the cause of AIDS. A French team led by virologist Luc Montagnier, who was then at the Pasteur been transmitted to humans on at least Around this time, Hahn published a paper Institute, also isolated the retrovirus from seven occasions.” in Science (8), of which the noted prima- a patient (6); Gallo is thus regarded as the As for how these transmissions occurred, tologist Jane Goodall was a coauthor. “Our codiscoverer of HIV-1. Hahn and her team wrote that among wild- work in Gombe with Jane Goodall was very “ AIDS as a Zoonosis living primates, biting and predation repre- instrumental because Gombe is the only sent the most likely means of cross-species place in the world where SIVcpz-infected In 1985, Hahn and Shaw were recruited to infection.” Hunting bushmeat “provides a wild chimpanzees tolerate the presence of initiate human retrovirus research efforts at plausible explanation for the transmission human observers,” Hahn says. Of an initial the University of Alabama at Birmingham’s of lentiviruses to humans.” The hypothesis 58 wild chimpanzees tested, one healthy Comprehensive Cancer Center. With perse- drew attention to the bushmeat trade and 23-y-old sexually active male from Gombe verance, they both rose up the ranks at the related factors, such as the effects of com- National Park, Tanzania, was positive for university. Over time, Hahn became a ten- mercial logging and the link between so- SIVcpz infection. The report demonstrated ured professor in the Departments of Medi- cioeconomic factors and disease. Now, the the feasibility of the noninvasive approach cine and Microbiology and then served as the challenge was to directly study SIVcpz in but left open important questions, such as: codirector of the Center for AIDS Research. wild chimpanzees using ethical means. Hahn What is the natural history of the infection? Hahn and Shaw have always enjoyed “good says, “Primates, and in particular apes, are chemistry,” as she says, both in and out of the dear to my heart.” Chimpanzee Reservoirs of HIV-1 laboratory, and they married in 1988. For over three years, Hahn and her team A summary of the pair’s studies on the Novel Research Tool tenaciously tracked the AIDS-like viruses that origin of AIDS was published in Science in Hahn credits two of her former students, afflict chimpanzees. In July 2006, a paper in January 2000 (7). As for nearly all of Hahn Mario Santiago and Brandon Keele, with Science (9) announced a significant discovery. and Shaw’s work, the report foreshadowed establishing then-novel noninvasive methods Hahn and Shaw’s team, in collaboration their later investigations. “Humans are not that allowed the team to diagnose and mo- with Paul Sharp, an evolutionary biologist the natural hosts of either HIV-1 or HIV-2,” lecularly characterize SIV infections in wild- at the University of Edinburgh, and Martine the team wrote. “Instead, these viruses have living chimpanzees, gorillas, sooty manga- Peeters, a virologist at the Institute of Re- enteredthehumanpopulationasaresultof beys, and other primates. Santiago established search and Development and the University zoonotic, or cross-species, transmission. We methods to amplify SIVcpz nucleic acids of Montpellier 1, wrote in the report: “The now know of at least 18 distinct primate from fecal RNA, and Keele began working findings presented here, together with prior lentiviruses that naturally infect different with RNAlater, a solution used to preserve studies, provide for the first time a clear African primates.” Lentiviruses are members fecal samples. Keele subsequently developed picture of the origin of HIV-1 and the seeds of a family of retroviruses characterized by a highly sensitive fecal-based antibody assay. of the AIDS pandemic.” a long incubation period. The researchers Collaborating primatologists would describe The discovery provided a crucial link in noted that two such simian immunodefi- themselves as being “glorified pooper scoop- the chain of evidence implicating SIVcpz in ciency viruses, SIVcpz from chimpanzees and ers,” but the effort was simple and ingenious. the origin of HIV-1 and AIDS. The report SIVsmm from sooty mangabeys, “are the The noninvasive diagnostic methods yielded also displayed the creative thinking of Hahn cause of acquired immunodeficiency syn- critical information without harming the en- and Shaw’s team. Their noninvasive techni- drome in humans. Together, they have dangered species. ques enabled the detection of antibodies and 2of3 | www.pnas.org/cgi/doi/10.1073/pnas.1305711110 Viegas Downloaded by guest on September 29, 2021 PROFILE nucleic acids in fecal samples collected from noninvasive techniques that had uncovered for successful viral replication within a new the forest floor.
Recommended publications
  • A Truncated Nef Peptide from Sivcpz Inhibits the Production of HIV-1 Infectious Progeny
    viruses Article A Truncated Nef Peptide from SIVcpz Inhibits the Production of HIV-1 Infectious Progeny Marcela Sabino Cunha 1,†, Thatiane Lima Sampaio 1,†, B. Matija Peterlin 2 and Luciana Jesus da Costa 1,* 1 Departamento de Virologia—Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373—CCS—Bloco I, Rio de Janeiro 21941-902, Brazil; [email protected] (M.S.C.); [email protected] (T.L.S.) 2 Departments of Medicine, Microbiology and Immunology, University of California, San Francisco, 533 Parnassus Avenue, San Francisco, CA 94143, USA; [email protected] * Correspondence: [email protected]; Tel.: +55-21-2560-8344 (ext. 117); Fax: +55-21-2560-8344 † These authors contributed equally to this work. Academic Editor: Andrew Mehle Received: 29 February 2016; Accepted: 14 June 2016; Published: 7 July 2016 Abstract: Nef proteins from all primate Lentiviruses, including the simian immunodeficiency virus of chimpanzees (SIVcpz), increase viral progeny infectivity. However, the function of Nef involved with the increase in viral infectivity is still not completely understood. Nonetheless, until now, studies investigating the functions of Nef from SIVcpz have been conducted in the context of the HIV-1 proviruses. In an attempt to investigate the role played by Nef during the replication cycle of an SIVcpz, a Nef-defective derivative was obtained from the SIVcpzWTGab2 clone by introducing a frame shift mutation at a unique restriction site within the nef sequence. This nef -deleted clone expresses an N-terminal 74-amino acid truncated peptide of Nef and was named SIVcpz-tNef. We found that the SIVcpz-tNef does not behave as a classic nef -deleted HIV-1 or simian immunodeficiency virus of macaques SIVmac.
    [Show full text]
  • Week 6 AIDS Part
    Age of AIDS, Part Two. Scientific Breakthroughs National Institutes of Health, Bethesda, Maryland. >>NARRATOR: At the NIH, research scientists were trying to identify the mysterious agent that was causing the epidemic. >>DR. ANTHONY FAUCI: It was a period of evolving mystery. You couldn't see it, you look in the cells, you couldn't grow it, at least initially, and most everybody thought it was virus. >>NARRATOR: And many people thought that this man at the NIH, Dr. Robert Gallow, had a head start in the race to identify the virus. >>GEORGE SHAW, M.D. Ph.D.: I arrived in Bob Gallow's lab in 1983 and it was time of extraordinary excitement. >>NARRATOR: Four years earlier, Dr. Gallow had achieved a scientific breakthrough when he isolated a special virus, a retrovirus which caused leukemia. >>They were called HTLV 1 for human T-cell Leukemia Virus Type 1 and HTLV Type 2. Those viruses were actually prime candidates for the cause of AIDS. >>NARRATOR: Dr. Gallow and his team, convinced the AIDS virus was related to the HTLV, began probing the blood from an AIDS patient, using the same techniques he had used to discover the leukemia virus. >>DR. GALLOW: We were looking for HTLV-relatedness. We were looking for the AIDS virus to be related to the leukemia virus, a retrovirus, same family, but different. >>NARRATOR: But when Gallow cultured T-cells blood from the AIDS patients, he could find no markers of the HTLV. For Gallow, the idea that the AIDS virus could be anything except a variation of the HTLV seemed unthinkable.
    [Show full text]
  • CURRICULUM VITAE, July 2021
    CURRICULUM VITAE, July 2021 MARTIN NICHOLAS MULLER Department of Anthropology University of New Mexico MSC 01 1040 Albuquerque, NM 87131-0001 USA e-mail: [email protected] websites: http://mnmuller.wordpress.com/ http://kibalechimpanzees.wordpress.com/ Education 2002 University of Southern California, Ph.D. in Anthropology 1994 University of Southern California, B.A. in Anthropology (Summa Cum Laude) Research Interests Behavioral ecology, Reproductive ecology, Endocrinology, Primate models in human evolution Academic Positions 2021- University of New Mexico, Department of Anthropology Professor 2011- 2021 University of New Mexico, Department of Anthropology Associate Professor 2007-2011 University of New Mexico, Department of Anthropology Assistant Professor 2004-2007 Boston University, Department of Anthropology Assistant Professor 2004 Harvard University, Department of Anthropology Postdoctoral Fellow 2003 University of Michigan, Department of Anthropology Visiting Research Investigator 1999-2002 Harvard University, Department of Anthropology Postdoctoral Fellow Professional Service 2018- Editorial Board Member, American Journal of Physical Anthropology 2013- Scientific Executive Committee, The Leakey Foundation 2010- Consulting Editor, Human Nature Awards and Fellowships 1998 Haynes Foundation Dissertation Fellowship 1994 University of Southern California, All-University Pre-Doctoral Merit Fellowship 1994 Phi Beta Kappa 1990 University of Southern California, Dean’s Scholarship Active Research Grants 2019 National Science Foundation. The evolutionary origins of leadership in chimpanzees: from individual minds to collective action. PIs: Alexandra Rosati (UM), Zarin Machanda (Tufts), Melissa Emery Thompson (UNM), and Martin Muller (UNM) Completed Research Grants 2015 National Institutes of Aging (PI: Melissa Emery Thompson). Biodemography of Aging in Wild Chimpanzees. (5-year grant) Co-Investigator. 2014 National Science Foundation. Developmental integration and the ecology of life histories in phylogenetic perspective.
    [Show full text]
  • The AIDS Epidemic and Its Spread in the for Additional Reading United States and the World
    © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION CHAPTER© Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE The OR DISTRIBUTION AIDS NOT FOR SALE OR DISTRIBUTION 1 Epidemic © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION LOOKING AHEAD © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC CHAPTER NOT FOR SALEJune 5,OR 2011 DISTRIBUTION marked 30 years since the Centers forNOT Disease FOR Control SALE and ORPrevention DISTRIBUTION (CDC) reported the fi rst cases of AIDS in the United States in its weekly Morbidity OUTLINE and Mortality Weekly Report (MMWR). The chronological milestone provides an opportunity to refl ect upon the status of HIV/AIDS in the world today. Since these Looking Ahead fi rst fi ve cases were reported, nearly 600,000 people have died in the United States as a result of HIV/AIDS.© Jones Worldwide, & Bartlett 30 million Learning, people LLChave died of HIV-related © JonesIntroduction & Bartlett Learning, LLC causes. There is stillNOT no vaccineFOR SALE available OR to DISTRIBUTIONprevent this viral disease. However, thereNOT TheFOR Early SALE Years OR DISTRIBUTION remains hope that this viral disease will be conquered one day. Development of anti- The First Observations virals to treat patients, along with improved HIV diagnosis methods, have increased The Breakthrough the life expectancy of U.S. patients after HIV diagnosis from 10.5 to 22.5 years. Another AIDS Virus This opening chapter introduces acquired immune deficiency syndrome (AIDS) A Pandemic by© exploringJones & the Bartlett development Learning, of its epidemic LLC in the United States and© Jonesthe world & BartlettOrigin Learning, of the AIDS LLC Epidemic andNOT by FORdescribing SALE the ORresearch DISTRIBUTION to uncover its cause.
    [Show full text]
  • New Claims from Paul Sharp - but Has the Source of HIV-1 Really Been Located?
    New Claims from Paul Sharp - But Has the Source of HIV-1 Really Been Located? Introduction February 2006. In recent days there has been much press coverage about new claims by American, British and Belgian scientists that they have discovered the geographical source of AIDS. These researchers have apparently detected simian immunodeficiency viruses (SIVs) that are closely related to the AIDS pandemic virus, HIV-1, in the stools of wild chimpanzees living in the very south-eastern corner of Cameroon, in western Africa. Much of this new information is important and valuable. However, much of the accompanying analysis is exaggerated, and not for the first time seems to be driven by an underlying desire on the part of the authors to bolster the bushmeat theory of origin of AIDS, which proposes that humans first got infected through the butchery and consumption of chimpanzee bushmeat. In fact, as I shall demonstrate, their claims of having established the source of HIV-1 and AIDS are far from convincing. Furthermore, their new findings are as consistent with the oral polio vaccine (OPV) theory of origin as they are with the bushmeat theory. [See note at end of this section for explanation of OPV theory.] The new information about the Cameroonian chimps was released in February 2006 at the 13th Conference on Retroviruses and Opportunistic Infections in Denver, Colorado, where important speeches were made by Brandon Keele, from the lab of microbiologist Beatrice Hahn at the University of Alabama in Birmingham (US); by Fran van Heuverswyn, from Martine Peeters' lab in Montpellier, France; and by Hahn's long-time collaborator, the geneticist Paul Sharp, who is based at the University of Nottingham, UK.
    [Show full text]
  • Comparative Genomics of Ape Plasmodium Parasites Reveals Key Evolutionary Events Leading to Human Malaria
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2016 Comparative Genomics of Ape Plasmodium Parasites Reveals Key Evolutionary Events Leading to Human Malaria Sesh Alexander Sundararaman University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Evolution Commons, Genetics Commons, and the Microbiology Commons Recommended Citation Sundararaman, Sesh Alexander, "Comparative Genomics of Ape Plasmodium Parasites Reveals Key Evolutionary Events Leading to Human Malaria" (2016). Publicly Accessible Penn Dissertations. 2046. https://repository.upenn.edu/edissertations/2046 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2046 For more information, please contact [email protected]. Comparative Genomics of Ape Plasmodium Parasites Reveals Key Evolutionary Events Leading to Human Malaria Abstract African great apes are infected with at least six species of P. falciparum-like parasites, including the ancestor of P. falciparum. Comparative studies of these parasites and P. falciparum (collectively termed the Laverania subgenus) will provide insight into the evolutionary origins of P. falciparum and identify genetic features that influence host tropism. Here we show that ape Laverania parasites do not serve as a recurrent source of human malaria and use novel enrichment techniques to derive near full-length genomes of close and distant relatives of P. falciparum. Using a combination of single template amplification and deep sequencing, we observe no evidence of ape Laverania infections in forest dwelling humans in Cameroon. This result supports previous findings that ape Laverania parasites are host specific and have successfully colonized humans only once. To understand the determinants of host specificity and identify genetic characteristics unique to P.
    [Show full text]
  • Stephen Hahn Commissioner Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993
    Stephen Hahn Commissioner Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Dear Dr. Hahn: We are experts in virology, epidemiology, vaccinology, infectious disease, clinical care and public health. A vaccine(s) is needed to curtail the COVID-19 pandemic. We are committed to promoting the broad uptake of safe and effective COVID-19 vaccines. The need is urgent but all vaccines must be rigorously studied to determine whether their benefits exceed their risks. For this reason, we urge that COVID-19 vaccines are made widely available only after the Food and Drug Administration (FDA) has been able to evaluate safety and efficacy data from completed Phase 3 clinical trials. The FDA’s review must be as thorough as has been the case for previous vaccine candidates. As transparency will be critical for fostering public confidence and maximizing vaccine use, the open meetings of the FDA’s Vaccines and Related Biologics Product Approval (VRBPAC) Committee must be an essential part of the authorization and approval processes. Several COVID-19 vaccine candidates are now in Phase 3 trials. We hope one or more of them will soon prove to be both safe and effective. The decisions to fund and produce many millions of doses ahead of the trial results should save many months in providing approved vaccines to the American public. In short, productive collaborations between scientists, the pharmaceutical industry and the federal government may bring us to a remarkable and historic achievement – the creation of a vaccine within a year after this pandemic virus was first identified.
    [Show full text]
  • Within-Host Evolution of Hiv-1: Novel Pathways of Virus Escape from Cellular and Humoral Immunity
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2016 Within-Host Evolution Of Hiv-1: Novel Pathways Of Virus Escape From Cellular And Humoral Immunity Edward Kreider University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Microbiology Commons Recommended Citation Kreider, Edward, "Within-Host Evolution Of Hiv-1: Novel Pathways Of Virus Escape From Cellular And Humoral Immunity" (2016). Publicly Accessible Penn Dissertations. 2406. https://repository.upenn.edu/edissertations/2406 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2406 For more information, please contact [email protected]. Within-Host Evolution Of Hiv-1: Novel Pathways Of Virus Escape From Cellular And Humoral Immunity Abstract Longitudinal HIV-1 single genome sequencing (SGS), which permits unambiguous genetic characterization of circulating viral strains without introduction of PCR error, can be used to identify sites in the viral genome that are under selective pressure. Following transmission, the earliest sites under positive selection often fall in cytotoxic T lymphocyte (CTL) epitopes. During escape from CTL immune pressure, viral sequences typically exhibit nonsynonymous mutations within the span of the cognate T cell epitope. I applied SGS to study sequence evolution in the HIV-1 5’ leader sequence, which is thought to be translationally silent. I observed mutational patterns consistent with CTL escape and demonstrated that the HIV-1 5’ leader expresses T cell antigens from non-canonical one-off AUG codons (e.g. CUG). While these non-canonical start codons can be mutated during CTL escape, a reverse transcriptase overextension error periodically restores a one-off AUG within the 5’ leader.
    [Show full text]
  • Molecularbiologyof Humant-Lymphotropicretroviruses
    [CANCER RESEARCH (SUPPL.) 45, 45395-45445, September1985] MolecularBiologyof HumanT-LymphotropicRetroviruses Flossie Wong-Staal, Lee Ratner, George Shaw, Beatrice Hahn, Mary Harper, Genoveffa Franchini,and Robert Gallo LaboratoryofTumorCellBiology,NationalCancerInstitute,Bethesda,Maryland20205 Abstract 7),a recentlyrecognizeddiseasecharacterizedbyopportunistic infectionsasa resultofsevereimmunosuppressionandOKT4 Thegenericnamefora familyofhumanT-Iymphotropicretro helperT-celldepletion(8).Consistentwithdifferencesintheirin virusesisHTLV.Two of thethreemembersinthisfamilyhave vivodiseasespectrums,HTLV-Iand HTLV-IItransformT-lym beenlinkedetiologicallyto humandiseases:HTLV-lwith adult phocytesin vitro,whileHTLV-lIlis highlycytopathicandhasno T-celIleukemiaandHTLV-Illwiththeacquiredimmunodeficiencyapparenttransformingactivity.However,allthreevirusgroups syndrome.InadditiontotheirT-celltropismanda numberof shareat leastthesecommonproperties:tropismforT-lympho othercommonbiologicalandbiochemicalproperties,themost cytes;somedegreeof cytopathyfor the infectedcells;induction uniquecommonfeaturesof thesevirusesfroma molecular of multinudeatedgiantcellsandformationofsyncytia;aMg@@ biologicalpointofviewarethepresenceofthex-Iorgenetowards preferringreversetranscnptaseofhighmolecularweight;a small the 3' end of the genomeand the phenomenonofa virus majorcoreprotein(p24);commonepitopesofgagandenvelope inducedtrans-actingfactorin activationof transcriptioninitiated proteins;anda likelyAfricanorigin. in the virallongterminalrepeat.Thesefeaturesmaynot onlybe
    [Show full text]
  • HIV/AIDS Research at the NCI:A Record of Sustained Excellence
    HIV/AIDS Research at the NCI: A Record of Sustained Excellence National Cancer Institute Institute Cancer National U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health HIV/AIDS Research at the National Cancer Institute: A Record of Sustained Excellence Letter from the Director of the CCR ............................................................................................................1 The Early NCI Retrovirus Experience ...........................................................................................................2 A New Virus Revealed ......................................................................................................................2 Risk Factors ........................................................................................................................................4 A Tale of Two Diseases ...............................................................................................................................5 Treating the Infection .........................................................................................................................5 Treating the Cancers .........................................................................................................................6 HIV and the Immune System: How They Interact........................................................................................8 Susceptibility to Infection, AIDS, and Related Diseases ..........................................................................10
    [Show full text]
  • Dr Robert Gallo Interview 02 November 4 1994 Interview with Dr
    Dr Robert Gallo Interview 02 November 4 1994 Interview with Dr. Robert Gallo This is the second oral history interview with Dr. Robert Gallo of the National Cancer Institute about the history of AIDS at the National Institutes of Health. The date is 4 November 1994. The interviewers are Dr. Victoria A. Harden, Director, NIH Historical Office, and Dennis Rodrigues, program analyst, NIH Historical Office. Harden: Dr. Gallo, when we ended the first interview, we had set the stage for the discussion of AIDS. We had talked about when [Dr. James] Jim Curran [of the Centers for Disease Control and Prevention] came to the NIH [National Institutes of Health] and was prodding you to go into AIDS research. Much of your early work has been detailed in many different places–in your book and in a variety of other publications–so what we would like to do in this interview is to have a few points amplified, not to attempt to recount all the facts. One of the key questions that has come up over and over again is how, when a new disease appears, can it be demonstrated that a particular agent is the cause of it? Chronologically, the French isolated their virus, LAV, in 1983, but they did not demonstrate conclusively that there was a causal link between their virus and AIDS. You waited until May 1984, and then published four papers in Science to do this. In fact, you wrote to [Dr.] Jean-Claude Chermann noting that you wanted to wait to publish in order to obtain a certain number of papers to establish the etiology.
    [Show full text]
  • CXCR6-Mediated Simian Immunodeficiency Virus
    CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections Katherine Wetzel, Yanjie Yi, Sarah Elliott, Dino Romero, Béatrice Jacquelin, Beatrice Hahn, Michaela Muller-Trutwin, Cristian Apetrei, Ivona Pandrea, Ronald Collman To cite this version: Katherine Wetzel, Yanjie Yi, Sarah Elliott, Dino Romero, Béatrice Jacquelin, et al.. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections. Journal of Virology, American Society for Microbiology, 2017, 91 (4), pp.e01626-16. 10.1128/jvi.01626-16. pasteur- 01960612 HAL Id: pasteur-01960612 https://hal-pasteur.archives-ouvertes.fr/pasteur-01960612 Submitted on 19 Dec 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. PATHOGENESIS AND IMMUNITY crossm CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections Katherine S. Wetzel,a Yanjie Yi,a Sarah T. C. Elliott,a Dino Romero,a Beatrice Jacquelin,b Beatrice H. Hahn,a Michaela Muller-Trutwin,b Cristian Apetrei,c Ivona Pandrea,c Ronald G.
    [Show full text]